Gates Foundation's programs complement new global plan to prevent 2M child deaths

NewsGuard 100/100 Score

John Grove, a senior program officer at the Bill & Melinda Gates Foundation, and Gretchen Meller, a program officer at the foundation, write in the group's "Impatient Optimists" blog, "By addressing [pneumonia and diarrhea] together, the [Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD)] goes to the heart of the matter: both diseases are caused by a range of pathogens, and no single intervention alone will eliminate either disease. But, by addressing the complexity of common causes and risk factors, and implementing common prevention strategies and interventions and similar delivery platforms in clinics, communities and schools, prevention and treatment can become stronger tools by actually getting into the hands of the caregivers." They provide information on the diseases' impacts on childhood morbidity and mortality. "The foundation's pneumonia and enteric and diarrheal diseases strategies share similar goals -- to accelerate the reduction in global burden of these largely preventable pathogen-caused illnesses," they note (4/12).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rapid molecular testing transforms treatment for community-acquired pneumonia